Axitinib-d3 2 2-trifluoroacetic acid) 5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(6-(methylamino)-9H-purin-9-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite

5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(6-(methylamino)-9H-purin-9-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite

InChiKey: WBHVHPLFRGISDD-ROUUACIJSA-N

selective and orally active S1P1 receptor modulator

MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis

β-Endorphin inhibits the conduction of pain and agitation of nociceptors to exert an analgesic effect

Axitinib-d3 2 2-trifluoroacetic acid) 5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(6-(methylamino)-9H-purin-9-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramiditeAxitinib d3 (AG 013736 d3) is deuterium labeled Axitinib. Axitinib is a multi targeted tyrosine kinase inhibitor with IC50s of 0. 1, 0. 2, 0. 1 0. 3, 1. 6 nM for VEGFR1, VEGFR2, VEGFR3 and PDGFR, respectively. Product information CAS Number: 1126623 89 9 Molecular Weight: 389. 49 Formula: C22H18N4OS Chemical Name: (E) N (methyl d3) 2 ((3 (2 (pyridin 2 yl)vinyl) 1H indazol 6 yl)thio)benzamide Smiles: [2H]C([2H])([2H])NC(=O)C1=CC=CC=C1SC1=CC2NN=C( C=C